Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.34 +0.25%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $22.00 (from $20.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- JPMorgan Upgrades Telekom Malaysia Bhd (T:MK) (MYTEF) to Neutral
- Royalty Pharma (RPRX) PT Raised to $68 at TD Cowen
- The Trade Desk (TTD) PT Raised to $14 at Evercore ISI
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
